Techniques for Resolving Discordant HER2 Status in Pathology Images for Diagnosing Breast Cancer
Copyright © Targeted News Service 2026
2026-07-28
ALEXANDRIA, Virginia, July 28 -- TEMPUS AI, INC., Chicago, Illinois has been assigned a patent (No. US 12694302 B2, initially filed May 6, 2022) developed by three inventors Joshua S.K. Bell, Chicago, Illinois; Catherine Igartua, Chicago, Illinois; and Nike Tsiapera Beaubier, Miami, Florida, for "Techniques for resolving discordant HER2 status in pathology images for diagnosing breast cancer." . . .
